CN
Search...
About Us
Group Overview
Management Team
Milestones of Chipscreen
Group Honors
Social Responsibility
Core Technologies and R&D
Core Technologies
Scientific Committee
R&D System
Drug Lifecycle Management
Pipeline
Pipelines
News & Events
Company News
Media Coverage
Notices & Announcements
Video Library
Investors
Company Announcements
Periodic Reports
Career Development
Contact Us
Contact Details
CN
EN
News & Events
Chipscreen Highlights: Stay Updated on Recent Hot Topics
Home
News & Events
Company News
Media Coverage
Notices & Announcements
Video Library
Select year
2026
2025
2024
2023
2022
Earlier
shown/page
5
5
10
15
20
2025.07.27
ESMO 2025丨Chidamide HDAC+IO Study Selected for Featured Presentation
ESMO 2025丨Chidamide HDAC+IO Study Selected for Featured Presentation
Full text
2025.07.09
A Milestone in First-Line DLBCL Treatment! Topline Results from Chidamide DEB Study Achieve Primary EFS Endpoint
A Milestone in First-Line DLBCL Treatment! Topline Results from Chidamide DEB Study Achieve Primary EFS Endpoint
Full text
2025.05.31
ASCO 2025 Highlight | Complete Response Rate Surpasses 95%! Chidamide Combination Therapy Shows Promising Results in Oral Presentation for Untreated NK/T-Cell Lymphoma
ASCO 2025 Highlight | Complete Response Rate Surpasses 95%! Chidamide Combination Therapy Shows Promising Results in Oral Presentation for Untreated NK/T-Cell Lymphoma
Full text
2025.05.15
Chidamide (Epidaza®) - 19 studies to be presented at EHA 2025
Chidamide (Epidaza®) - 19 studies to be presented at EHA 2025
Full text
2025.04.18
CSCO Guidelines Major Update for First-line DLBCL: Epidaza® Receives First Authoritative Recommendation
CSCO Guidelines Major Update for First-line DLBCL: Epidaza® Receives First Authoritative Recommendation
Full text
04
05
06
...
24
Media contact
（+86）0755-36993500
pr@juliucq.com
